+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Theravance Biopharma - logo

Theravance Biopharma is a biopharmaceutical company that develops and commercializes human therapeutics. The company offers VIBATIV (telavancin), a bactericidal, once-daily injectable antibiotic. In addition, it has numerous product candidates, including Revefenacin (TD-4208), Axelopran, Velusetrag, TD-6450 and others. It also focuses on various drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. Founded in 2013, it is based in George Town, the Cayman Islands.

Multidrug Resistant Bacteria Global Market Report 2024 - Product Thumbnail Image

Multidrug Resistant Bacteria Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Crohn's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Crohn's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 240 Pages
  • Global
From
From
From
From
Adrenergic uptake inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Adrenergic uptake inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
JAK inhibitors - Competitive Landscape, 2023 - Product Thumbnail Image

JAK inhibitors - Competitive Landscape, 2023

  • Report
  • April 2023
  • 180 Pages
  • Global
From
Orthostatic Hypotension Drugs Market 2022-2026 - Product Thumbnail Image

Orthostatic Hypotension Drugs Market 2022-2026

  • Report
  • March 2022
  • 120 Pages
  • Global
From
Dysautonomia or Autonomic Dysfunction - Pipeline Insight, 2024 - Product Thumbnail Image

Dysautonomia or Autonomic Dysfunction - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
From
From
Gastroparesis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Gastroparesis - Market Insight, Epidemiology and Market Forecast - 2034

  • Drug Pipelines
  • February 2024
  • 144 Pages
  • Global
From
From
Loading Indicator